Abstract
Although nasal continuous positive airway pressure (nCPAP) treatment is the most efficient therapy for obstructive sleep apnea (OSA), compliance with therapy is poor because of several side effects. Among these adverse effects some are related to the reactions of the nose to nCPAP which are briefly described. In a long-term survey of 109 OSA patients, 80.6% continued nCPAP for at least 3 years until the last follow-up. Follow-up ranged between 0.8 and 109 months with a mean time of 43 (SD ± 24.7) months. Among all patients treated with nCPAP, only 46.6% met our criteria for long-term compliance, defined as a mean use of the CPAP machine for at least 5 hours per night. Within the objective measures such as age, body mass index, neck circumference, nasal airflow, apnea-hypopnea index, minimal oxygen saturation, and level of nCPAP pressure, no predictive factor for daily use of nCPAP could be found. However, pretherapeutic daytime somnolence (measured by visual analogue scale and Epworth Sleepiness Scale) and its improvement obtained from the therapy showed a significant effect on the daily use of the CPAP machine.
Similar content being viewed by others
References
Sullivan CE, Berthon-Jones M, Issa FG, EversL. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981;1:862–865
Jenkinson C, DaviesRJO, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnea: a randomized prospective parallel trial. Lancet 1999;353:2100–2105
Ballester E, Badia JR, HernandezL, et al. Evidence of effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159:495–501
Brandenburg U, Weiner M, Becker J, et al. Haemodynamics and sleep structure in the discontinued nCPAP test in obstructive sleep apnoea syndrome [German]. Pneumologie 1993;47:181–183
Krieger J, Weitzenblum E, Monassier JP, StoeckelC, Kurtz D. Dangerous hypoxemia during continuous positive airway pressure treatment of obstructive sleep apnea [letter]. Lancet 1983;2:1429–1430
Anderson AP, Alving J, Lildholdt T, Wulff C. Obstructive sleep apnea initiated by a lax epiglottis: a contraindication for continuous positive airway pressure. Chest 1987;91:621–623
Pépin JL, Leger P, Veale D, et al. Side effects of nasal continuous positive airway pressure in sleep apnea syndrome. Study of 193 patients in two French sleep centers. Chest 1995;107:375–381
Strumpf DA, Harrop P, Dobbin J, MillmanRP. Massive epistaxis from nasal CPAP therapy. Chest 1989;95:1141–1141
Jarjour NN, Wilson P. Pneumocephalus associated with nasal continuous positive airway pressure in a patient with sleep apnea syndrome. Chest 1989;96:1425–1426
Bamford CR, Quan SF. Bacterial meningitis—a possible complication of nasal continuous positive airway pressure therapy in a patient with obstructive sleep apnea syndrome and a mucocele. Sleep 1993;16:31–32
Zwacka G, Scholle S, Kemper G, Rieger B. Nasal CPAP therapy for infants with congenital stridor. Sleep Breath 1997/98;2:085–096
Loftus BC, Ahn J, Haddad J. Neonatal nasal deformities secondary to nasal continuous positive airway pressure. Laryngoscope 1994;104:1019–1022
Mortimore IL, Whittle AT, Douglas NJ. Comparison of nose and face mask CPAP therapy for sleep apnoea. Thorax 1998;53:290–292
Verse T. Nebenwirkungen der nasalen CPAP-Ventilationstherapie. HNO 2000;48:706–715
Verse T, Lehnhardt E, Pirsig W, Junge-Hülsing B, Kroker B. Otorhinolaryngological side effects of nocturnal nasal ventilation therapy with continuous positive airway pressure (nCPAP). Laryngorhinootologie 1999;78:491–496
Wiest GH, Ficker JH, Müller A, HahnEG. Nebenwirkungen der nCPAP-Therapie beim obstruktiven Schlafapnoesyndrom. Ursachen und Therapie. Atemw-Lungenkrkh 1998;24:95–102
Lojander J, Brander PE, ÄmmäläK. Nasopharyngeal symptoms and nasal continuous positive airway pressure therapy in obstructive sleep apnea syndrome. Acta Otolaryngol 1999;119:497–502
Kalan A, Kenyon GS, Seemungal TAR, WedzichaA. Adverse effects of positive airway pressure therapy in sleep apnoea syndrome. J Laryngol Otol 1999;113:888–892
Nino-Murcia G, McCann CC, Bliwise DL, Guilleminault C, DementWC. Compliance and side effects in sleep apnea patients treated with nasal continuous positive airway pressure. West J Med 1989;150:165–169
Togias AG, Naclerio RM, Proud D, et al. Nasal challenge with cold, dry air results in release of inflammatory mediators: possible mast cell involvement. J Clin Invest 1985;76:1375–1381
Constantinidis J, Knöbber D, Steinhart H, Kuhn J, Iro H. Fine-structural investigations of the effect of nCPAP-mask application on the nasal mucosa. Acta Otolaryngol 2000;120:432–437
Richards GN, Cistulli PA, Ungar RG, Berthon-Jones M, SullivanCE. Mouth leak with nasal continuous positive airway pressure increases nasal airway resistance. Am J Respir Crit Med 1996;154:182–186
Becker H, Fett I, Nees E, Peter JH, von WichertP. Behandlung primärer und sekundärer Therapieversager der nCPAP-Behandlung bei Patienten mit Schlafapnoe. Pneumologie 1991;45:301–305
Wiest GH, Lehnert G, BrückWM, et al. A heated humidifier reduces upper airway dryness during continuous positive airway pressure therapy. Resp Med 1999;93:21–26
Grunstein RR. Sleep-related breathing disorders. 5. Nasal continuous positive airway pressure treatment for obstructive sleep apnea. Thorax 1995;50:1106–1113
Coppola MP. Controversies in sleep medicine—essay: The Emperor (and my patient) has no nose. Sleep Breath 1999;3:107–107
Massie CA, Hart RW, Peralez K, RichardsGN. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest 1999;116:403–408
Krieger J, Kurtz D. Objective measurement of compliance with nasal CPAP treatment for obstructive sleep apnoea syndrome. Eur Respir J 1988;1:436–438
Waldhorn RE, Herrick TW, Nguyen MC, et al. Long-term compliance with nasal continuous positive airway pressure therapy of obstructive sleep apnea. Chest 1990;97:33–38
Rauscher H, Popp W, Wanke T, Zwick H. Acceptance of CPAP therapy for sleep apnea. Chest 1991;100:1019–1023
Hoffstein V, Viner S, Mateika S, Conway J. Treatment of obstructive sleep apnea with nasal continuous positive airway pressure. Patient compliance, perception of benefits, and side effects. Am Rev Respir Dis 1992;145:841–845
Engleman HM, Martin SE, Douglas NJ. Compliance with CPAP-therapy in patients with sleep apnea/hypopnea syndrome. Thorax 1994;49:263–266
Hollandt JH, Kuhl S, Siegert R. Treatment of patients with the obstructive sleep apnoea syndrome (OSAS) using nasal continuous positive airway pressure (nCPAP). Part I: Long-term compliance with nCPAP. Laryngorhinootologie 1997;76:550–553
Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients’ mortality. Chest 1988;94:1200–1204
Rasche K, Orth M, Duchna HW, Ullrich HW, Schultze-WerninghausG. CPAP-Therapie bei obstruktivem Schlafapnoesyndrom: Nebenwirkungen und Akzeptanz im Langzeitverlauf. Med Klinik 1994;89:86–88
Kuhl S, Hollandt JH, SiegertR. Treatment of patients with obstructive sleep apnea syndrome (OSAS) with nasal continuous positive airway pressure (nCPAP). Part II: Side effects of nCPAP therapy—influence on long-term compliance. Laryngorhinootologie 1997;76:608–613
Hollandt JH, Mahlerwein M, Klaiber S, Siegert R. Langzeitakzeptanz von nCPAP (nasal continuous positive airway pressure) bei Patienten mit obstruktivem Schlafapnoe Syndrom [abstract]. HNO Informationen 2002;27:136–136
Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992;15:376–381
Meurice JC, Dore P, Paquereau J, et al. Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest 1994;105:429–433
Mayer-Brix J, Becker H, PeterJH. Nasal high pressure ventilation in obstructive sleep apnea syndrome. Theoretical and practical otorhinolaryngological aspects [German]. Laryngorhinootologie 1989;68:295–298
Sériès F; Pierre SS, Carrier G. Effects of surgical correction of nasal obstruction in the treatment of obstructive sleep apnea. Am Rev Respir Dis 1992;146:1261–1265
Ripberger R, Pirsig W. Long-term compliance with nasal CPAP treatment for obstructive sleep apnoea: prospective study in 50 patients [German]. Laryngorhinootologie 1994;73:581–585
Friedmann M, Tanyeri H, Lim JW, et al. Effects of improved nasal breathing on obstructive sleep apnea. Otolaryngol Head Neck Surg 2000;122:71–74
Biermann E. Nasal CPAP-therapy in obstructive sleep apnea syndrome: does functional rhinosurgery improve compliance?. Somnologie 2001;5:59–64
Dorn M, Pirsig W, Verse T. Management of patients with severe obstructive sleep apnea following rhinosurgical interventions. A pilot study. HNO 2001;49:642–645
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hollandt, J.H., Mahlerwein, M. Nasal Breathing and Continuous Positive Airway Pressure (CPAP) in Patients with Obstructive Sleep Apnea (OSA). Sleep Breath 7, 87–93 (2003). https://doi.org/10.1007/s11325-003-0087-7
Issue Date:
DOI: https://doi.org/10.1007/s11325-003-0087-7